Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, March 28, 2024 | Back issues
Courthouse News Service Courthouse News Service

Drugmakers

WASHINGTON - The Food and Drug Administration properly approved Coastal Pharmaceuticals' generic eye-drop drug, a federal judge ruled Monday, dismissing claims from ISTA Pharmaceuticals, which markets Xibrom and Bromday.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...